Clinical Trials Directory

Trials / Terminated

TerminatedNCT00593320

Stereotactic Radiosurgery (SRS) for Spine Metastases

Stereotactic Radiosurgery (SRS) for One or Two Localized Spine Metastases

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will evaluate the most effective radiation dose. Patients will be randomized (like flipping a coin) to receive either low dose stereotactic radiotherapy (defined as "14 Gy") or high dose stereotactic radiotherapy (defined as 18 Gy).

Detailed description

This study will evaluate the pain control and the quality of life of patients with spinal metastases using stereotactic radiotherapy. Stereotactic radiotherapy is referred to as "targeted therapy". It uses special equipment to position the patient and guide the focused beams of radiation toward the cancer and away from normal surrounding tissue. This higher dose technique may work better to kill cancer cells with fewer side effects than standard radiation therapy.

Conditions

Interventions

TypeNameDescription
RADIATIONStereotactic Radiosurgery

Timeline

Start date
2007-09-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2008-01-15
Last updated
2015-03-04
Results posted
2015-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00593320. Inclusion in this directory is not an endorsement.